Kryxana 200mg Tablet
Marketer
Novartis India Ltd
Salt Composition
Ribociclib (200mg)
Overview Kryxana 200mg Tablet
Metastatic breast cancer treatment may involve Kryxana 200mg tablets, an anti-cancer agent that inhibits cancerous cell proliferation and ultimately induces cell death. This medication addresses symptoms like breast masses, nipple bleeding, and breast shape alterations. Kryxana 200mg can be administered with or without food, typically alongside other medications. Treatment length is individualized based on patient response and needs; strictly adhere to your physician's prescribed dosage and duration. Regular blood monitoring is standard during therapy. Potential side effects include leukopenia (reduced white blood cell count), nausea, tiredness, diarrhea, alopecia (hair loss), vomiting, constipation, headache, and back pain. A known adverse reaction is neutropenia, characterized by decreased white blood cells and weakened immunity, increasing infection susceptibility. This effect typically resolves upon medication cessation. Prior to commencing Kryxana 200mg, disclose all pre-existing health issues and medications to your doctor. Further, inform your physician of pregnancy, pregnancy plans, or breastfeeding.
Primary Ingredients of Kryxana 200mg Tablet
No text provided. Please provide the text you would like me to rephrase.
Uses of Kryxana 200mg Tablet
Breast cancer with distant spread
Major Benefits of Kryxana 200mg Tablet:
Administer Kryxana 200mg Tablet according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid crushing, chewing, or fracturing it. Consumption may coincide with meals or be taken independently, however, consistent timing is recommended.
Common Side effects of Kryxana 200mg Tablet:
- Decreased white blood cell count
- Nausea
- Fatigue
- Diarrhea
- Hair loss
- Vomiting
- Constipation
- Headache
- Back pain
How to use Kryxana 200mg Tablet:
Consume Kryxana 200mg tablets according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing. This medication can be administered with or without food, though consistent timing is recommended.
How Kryxana 200mg Tablet works:
Oncasin 200mg tablets are a cancer treatment that inhibits the activity of key cell-growth proteins (kinases), thus impeding cancerous cell proliferation and ultimately leading to their demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Kryxana 200mg Tablet is not established as safe. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Kryxana 200mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Kryxana 200mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a 200mg Kryxana tablet might lead to adverse effects that impair driving ability. Fatigue, dizziness, or vertigo are possible side effects. Exercise caution while operating vehicles or machinery if you experience these symptoms.
KidneySAFE IF PRESCRIBED
The use of Kryxana 200mg tablets in individuals with kidney impairment is likely safe. Preliminary evidence indicates dose modification may not be necessary. However, physician consultation is recommended.
LiverCAUTION
For individuals with severe hepatic impairment, Kryxana 200mg tablets require careful administration. Dosage modification of Kryxana 200mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Kryxana 200mg Tablet :
NA
Facts to Know About Kryxana 200mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Piperazine-pyridines |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | CDK inhibitor |
3,018 People bought this recently